Gene: IDO1
Official Full Name: indoleamine 2,3-dioxygenase 1provided by HGNC
Gene Summary: This gene encodes indoleamine 2,3-dioxygenase (IDO) - a heme enzyme that catalyzes the first and rate-limiting step in tryptophan catabolism to N-formyl-kynurenine. This enzyme acts on multiple tryptophan substrates including D-tryptophan, L-tryptophan, 5-hydroxy-tryptophan, tryptamine, and serotonin. This enzyme is thought to play a role in a variety of pathophysiological processes such as antimicrobial and antitumor defense, neuropathology, immunoregulation, and antioxidant activity. Through its expression in dendritic cells, monocytes, and macrophages this enzyme modulates T-cell behavior by its peri-cellular catabolization of the essential amino acid tryptophan.[provided by RefSeq, Feb 2011]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA15238 | IDO1 Knockout cell line (AC16) | Human | IDO1 | 1:3-1:4 | negative | Online Inquiry |
| KOA30681 | IDO1 Knockout cell line (BEAS-2B) | Human | IDO1 | 1:3~1:4 | negative | Online Inquiry |
| KOA46108 | IDO1 Knockout cell line (U-2932) | Human | IDO1 | 1:2-1:4 | negative | Online Inquiry |
| KOA61494 | IDO1 Knockout cell line (TPC-1) | Human | IDO1 | 1:5-1:8 | negative | Online Inquiry |
| KOA76922 | IDO1 Knockout cell line (NCM460) | Human | IDO1 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.